{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:02:59Z","timestamp":1791874979707,"version":"4.3.4"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"\n Importance<\/jats:title>\n Androgen deprivation therapy (ADT) for men with prostate cancer (PCa) is associated with cardiovascular (CV) morbidity, yet the biological basis remains unclear. Recent studies have yielded conflicting results regarding the CV safety of gonadotropin-releasing hormone (GnRH) agonists vs antagonists.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To test the hypothesis that ADT is associated with accelerated coronary atherosclerosis and is more prominent with a GnRH agonist compared with a GnRH antagonist.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This open-label randomized clinical trial was conducted at 4 centers affiliated with a single academic institution in Atlanta, Georgia. Participants were men with nonmetastatic PCa without prior ADT exposure receiving pelvic radiotherapy with ADT of 6 months duration or longer. Patients were randomly assigned 1:1 to either the GnRH agonist leuprolide or the GnRH antagonist relugolix. Trial enrollment was completed between June 16, 2022, and March 6, 2024. Data analysis was completed between March 31, 2025, and June 23, 2025.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n Pelvic radiotherapy plus either GnRH agonist leuprolide or GnRH antagonist relugolix.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary end point was change in coronary artery total plaque volume (TPV), measured by coronary computed tomographic angiography completed at baseline and 12 months after ADT initiation. The secondary end point was change in coronary artery noncalcified plaque volume (NCPV). Other outcome measures included change in calcified plaque volume (CPV) and low-attenuation plaque volume (LAPV).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 65 men enrolled, 62 (31 in each arm) completed all study procedures for analysis. Mean (SD) age was 68.5 (8.5) years, and 35 of 62 participants (56%) were taking statins. Compared with relugolix, leuprolide was associated with a significantly greater 12-month increase in TPV (estimated difference, +68.9 mm\n 3<\/jats:sup>\n ; 95% CI, 23.2-114.5 mm\n 3<\/jats:sup>\n ;\n P<\/jats:italic>\n \u2009=\u2009.02) and NCPV (+64.5 mm\n 3<\/jats:sup>\n ; 95% CI, 31.6-97.3 mm\n 3<\/jats:sup>\n ;\n P<\/jats:italic>\n \u2009=\u2009.004) after adjustment for baseline plaque volume, age, and statin use. There was no significant difference in 12-month change in CPV or LAPV between patients treated with leuprolide vs relugolix.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial in men with localized PCa treated with radiation plus ADT, the GnRH agonist leuprolide was associated with greater coronary plaque progression within 12 months compared with the GnRH antagonist relugolix. This change was driven by an increase in noncalcified plaque volume and may be mediating ADT-associated CV risk.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT05320406<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamacardio.2025.5586","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:30:31Z","timestamp":1771432231000},"page":"459","source":"Crossref","is-referenced-by-count":12,"title":["Coronary Plaque Progression After Androgen Deprivation Therapy in Men With Prostate Cancer"],"prefix":"10.1001","volume":"11","author":[{"given":"Sagar A.","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Emory University, Atlanta, Georgia"},{"name":"Department of Urology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya K.","family":"Yadalam","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marly","family":"van Assen","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Cantu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Onnis","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andee","family":"Koo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subir","family":"Goyal","sequence":"additional","affiliation":[{"name":"Biostatistics Shared Resource at Winship Cancer Institute, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Biostatistics Shared Resource at Winship Cancer Institute, Emory University, Atlanta, Georgia"},{"name":"Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil T.","family":"Sebastian","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal R.","family":"Dhere","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W.","family":"Hershatter","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pretesh R.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiranj","family":"Chaudagar","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur E.","family":"Stillman","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo N.","family":"De Cecco","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Sanda","sequence":"additional","affiliation":[{"name":"Department of Urology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashesh B.","family":"Jani","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Emory University, Atlanta, Georgia"},{"name":"Department of Urology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Mandawat","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Emory University, Atlanta, Georgia"},{"name":"Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"hbr250027r1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/2051415816654048","article-title":"The modern role of androgen deprivation therapy in the management of localised and locally advanced prostate cancer.","volume":"9","author":"Gunner","year":"2016","journal-title":"J Clin Urol"},{"key":"hbr250027r2","doi-asserted-by":"publisher","first-page":"A16139","DOI":"10.1161\/circ.148.suppl_1.16139","article-title":"Rising cardiovascular mortality in prostate cancer patients: results from Surveillance, Epidemiology and End Results (SEER) database.","volume":"148","author":"Niroula","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"hbr250027r3","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/cncr.22933","article-title":"Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.","volume":"110","author":"Saigal","year":"2007","journal-title":"Cancer"},{"issue":"23","key":"hbr250027r4","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2004325","article-title":"Oral relugolix for androgen-deprivation therapy in advanced prostate cancer.","volume":"382","author":"Shore","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"hbr250027r5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jcct.2024.05.232","article-title":"Standards for quantitative assessments by coronary computed tomography angiography (CCTA): an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT).","volume":"18","author":"Nieman","year":"2024","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"9","key":"hbr250027r6","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/ehjci\/jeae115","article-title":"Prospective deep learning-based quantitative assessment of coronary plaque by computed tomography angiography compared with intravascular ultrasound: the REVEALPLAQUE study.","volume":"25","author":"Narula","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"11","key":"hbr250027r7","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1200\/JCO.2014.59.1792","article-title":"Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancer.","volume":"33","author":"O\u2019Farrell","year":"2015","journal-title":"J Clin Oncol"},{"issue":"48","key":"hbr250027r8","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A population-based study of cardiovascular disease mortality risk in US cancer patients.","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur Heart J"},{"issue":"6","key":"hbr250027r9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.eururo.2017.06.036","article-title":"Gonadotropin-releasing hormone agonists, orchiectomy, and risk of cardiovascular disease: semi-ecologic, nationwide, population-based study.","volume":"72","author":"Thomsen","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"hbr250027r10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.eururo.2014.11.039","article-title":"Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.","volume":"68","author":"Bosco","year":"2015","journal-title":"Eur Urol"},{"key":"hbr250027r11","doi-asserted-by":"publisher","first-page":"26220","DOI":"10.1038\/srep26220","article-title":"Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(-\/-) mice.","volume":"6","author":"Knutsson","year":"2016","journal-title":"Sci Rep"},{"issue":"8","key":"hbr250027r12","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.urolonc.2014.06.018","article-title":"GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model.","volume":"32","author":"Hopmans","year":"2014","journal-title":"Urol Oncol"},{"issue":"36","key":"hbr250027r13","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1093\/eurheartj\/ehae471","article-title":"Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.","volume":"45","author":"Nurmohamed","year":"2024","journal-title":"Eur Heart J"},{"issue":"3","key":"hbr250027r14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10554-011-9799-0","article-title":"The composition and extent of coronary artery plaque detected by multislice computed tomographic angiography provides incremental prognostic value in patients with suspected coronary artery disease.","volume":"28","author":"Miszalski-Jamka","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"issue":"4","key":"hbr250027r15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jcct.2013.08.006","article-title":"Coronary CT angiography versus intravascular ultrasound for estimation of coronary stenosis and atherosclerotic plaque burden: a meta-analysis.","volume":"7","author":"Fischer","year":"2013","journal-title":"J Cardiovasc Comput Tomogr"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2845162\/jamacardiology_patel_2026_br_250027_1778624871.70537.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:01:10Z","timestamp":1778684470000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2845162"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2025.5586","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}